First-in-class HIF2α antagonist safe and effective
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2018.3
Published Online: 2018-01-16
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2018-01-16
Article History
First Online: 16 January 2018